| 9/16/2021 |
Short Interest in Rosetta Genomics Ltd. (OTCMKTS:ROSGQ) Rises By 2,033.3% - Ticker Report |
Ticker Report |
... The firm’s 50 day moving average is $0.03 and its two-hundred day moving average is $0.06.Get Rosetta Genomics alerts: About Rosetta GenomicsRosetta Genomics Ltd. provides therapeutic, diagnostic product development and medical research service s. The company develops and commercializes new diagnostic tests based on various genomics markers, including DNA, microRNA and protein biomarkers and using various technologies, including, qPCR, microarrays, next generation sequencing and fluorescence in situ ... |
| 4/6/2021 |
Hadassah and MyBiotics to Collaborate for the Discovery of Microbiome-Based Therapy for Improving Cancer Immunotherapy | Markets Insider |
Business Insider |
REHOVOT and JERUSALEM , Israel , April 6, 2021 /PRNewswire/ -- MyBiotics Pharma Ltd. https://biomx.com/, a microbiome therapeutics company, and Hadasit Medical Research Service s and Development Ltd., the technology transfer office of Hadassah Medical Center, announced today that they have entered into a research collaboration and licensing agreement for the identification of microbiome-based therapeutics that will enhance the response to and reduce adverse effects of anti-PD-1 and anti-PD ... |
| 4/6/2021 |
MyBiotics, Hadassah to study impact of microbiome on cancer therapies |
timesofisrael.com |
MyBiotics Pharma Ltd. said Tuesday it will work with Hadasit Medical Research Service s and Development Ltd., the technology transfer arm of Hadassah Medical Center, to identify microbiome-based therapies to improve the impact of cancer immunotherapies in melanoma patients.MyBiotics has developed technologies to culture, ferment and deliver highly stable and diverse bacterial communities that can target different sites across the human body to restore the microbiome equilibrium.The collaboration ... |
| 9/24/2020 |
Global Biosimilars Partnering Terms and Agreements Report 2010-2020: Access to Over 140 Biosimilars Deal Records |
PR Newswire |
... Clinigen Cobra Biologics Coherus Biosciences Cook Pharmica CR Pharma Daiichi Sankyo Diabeloop Dr. Reddy's Laboratories Dyadic International EirGenix EMD Millipore Epirus Biopharmaceuticals Epivax European Commission Ewopharma Fujifilm Kyowa Kirin Biologics Fuji Pharma Genentech Hadasit Medical Research Service s and Development Helvetic Biopharma Henlius Biotech Hikma Pharmaceuticals Hoffmann La Roche Horizon 2020 Hospira Ipca Laboratories Jacobson Pharma JHL Biotech Laboratorios Liomont LABORATORIOS SAVAL Livzon Mabpharm Lupin Mab-Venture Biopharma Mabion mAbXience Merck ... |
| 8/3/2020 |
2015-2025 Global Proteinase Activated Receptor 2 Market Research by Type, End-Use and Region (COVID-19 Version) |
reportsmonitor.com |
... Company information, Sales, Cost, Margin, news etc. Chapter 10: Market Competition by Companies and Market Concentration Ratio Chapter 11: Market Impact by Coronavirus. Chapter 12: Industry Summary . Market Segment as follows: Key Companies Hadasit Medical Research Service s and Development Ltd Heptares Therapeutics Ltd Innovate Biopharmaceuticals Inc Key Types Larazotide Acetate AZ-8838 PZ-235 P-2pal18S Others Key End-Use Atopic Dermatitis Celiac Disease Pancreatitis Pulmonary Hypertension Others This report ... |
| 7/13/2020 |
How This Medical Research Services Company Is Making House Calls Safe in a Pandemic – Inc. |
Wordpress.com |
How This Medical Research Services Company Is Making House Calls Safe in a Pandemic Inc. from “phlebotomy” – Google News https://bit.ly/2Z4Zneg ... |
| 6/16/2020 |
State Dept coronavirus response gets kudos from Senate |
|
... to apply to federally-approved medical products and services. And it will waive the fee for these petitions. The move covers proposed trademarks for anti-COVID-19 products, and service marks for medical and medical research service s. But applicants must first have FDA approval for the products and services they want to trade- or service-mark. The military’s stop movement order has created a huge backlog in the number of ... |
| 4/21/2020 |
COVID-19 sets the stage for cyberattacks: How to protect your business while working remotely |
optricsinsider.com |
... a considerable rise in cyberattacks between January and March. Europol, Europe’s law enforcement agency, issued a warning that cyberattacks will increase in the healthcare industry as cybercriminals exploit the urgency of critical healthcare and medical research service s in these times. A recently reported cyberattack on one of the the Czech Republic’s largest COVID-19 testing laboratories is a perfect example; the attack was severe enough to cause a complete shutdown ... |
| 4/15/2020 |
COVID-19 sets the stage for cyberattacks: How to protect your business while working remotely |
manageengine.com |
... a considerable rise in cyberattacks between January and March. Europol, Europe’s law enforcement agency, issued a warning that cyberattacks will increase in the healthcare industry as cybercriminals exploit the urgency of critical healthcare and medical research service s in these times. A recently reported cyberattack on one of the the Czech Republic’s largest COVID-19 testing laboratories is a perfect example; the attack was severe enough to cause a complete shutdown ... |
| 3/16/2020 |
Dr. Philip D. Kiser Receives 2020 Pisart Award for Outstanding Achievements in Vision Science |
PR Newswire |
... Biological Chemistry , Nature Chemical Biology , the Journal of Clinical Investigation , Molecular Pharmacology , and PNAS . His research has also been recognized with a number of grants, honors, and awards, including a Department of Veterans Affairs Medical Research Service Career Development Award (CDA2), a March of Dimes Travel Award, a Burroughs-Wellcome Collaborative Research grant. "I am honored to receive the 2020 Pisart Award," said Dr. Kiser. "Like the Lighthouse Guild itself ... |
| 2/12/2020 |
Response to: 'Can solid-phase assays replace immunofluorescence for ANA screening? by Bizzaro |
BMJ |
Response to: ‘Can solid-phase assays replace immunofluorescence for ANA screening?’ by Bizzaro David S Pisetsky 1 , Peter E Lipsky 2 , Brad H Rovin 3 1 Department of Medicine and Immunology , Duke University Medical Center and Medical Research Service , VA Medical Center , Durham , North Carolina , USA 2 RILITE Research Institute , Charlottesville , Virginia , USA 3 Division of Nephrology , The Ohio State University, Wexner Medical Center , Columbus , Ohio , USA Correspondence to Dr ... |
| 1/16/2020 |
CenExel Leads Industry in Psychiatric Studies at Atlanta Center for Medical Research |
PR Newswire |
... their clients achieve their clinical research goals. About the Atlanta Center for Medical Research ACMR ( www.acmr.org ) is a fully dedicated 100,000 square foot, state-of-the-art research facility. We provide conscientious, recruitment-driven medical research service s that are pivotal in the advancement and treatment of illnesses of the central nervous system and other therapeutic areas. Our dedicated and experienced research teams conduct clinical trials with compassion and respect for ... |
| 10/18/2019 |
Role of ANA testing in the classification of patients with systemic lupus erythematosus |
BMJ |
Role of ANA testing in the classification of patients with systemic lupus erythematosus Free 1 Medicine , Duke University Medical Center , Durham , North Carolina , USA 2 Veterans Administration Medical Center , Medical Research Service , Durham , North Carolina , USA 3 Medicine , Ohio State University , Columbus , Ohio , USA 4 RILITE Institute , Charlottesville , Virginia , USA Correspondence to Dr David S Pisetsky, Medicine, Duke University Medical Center, Durham, NC 27705, USA; david.pisetsky(at)duke.edu autoantibodies The ... |
| 10/6/2019 |
Clinical Data Management: Why It Plays an Important Role in the Success of CRO Medical Research Services |
theglobaldispatch.com |
Dispatch Blogs / Science By Guest Author Clinical Data Management: Why It Plays an Important Role in the Success of CRO Medical Research Services The success of a CRO medical trial requires a high level of attention on accurate data creation and analysis. There are two main reasons why Clinical Data Management (CDM) is important. – Ensuring comprehensive data of the highest quality is generated and analysed during clinical trials – To obtain ... |
| 9/20/2019 |
Role of ANA testing in the classification of patients with systemic lupus erythematosus |
BMJ |
Role of ANA testing in the classification of patients with systemic lupus erythematosus David S Pisetsky 1 , 2 , 1 Medicine , Duke University Medical Center , Durham , North Carolina , USA 2 Veterans Administration Medical Center , Medical Research Service , Durham , North Carolina , USA 3 Medicine , Ohio State University , Columbus , Ohio , USA 4 RILITE Institute , Charlottesville , Virginia , USA Correspondence to Dr David S Pisetsky, Medicine, Duke University Medical Center, Durham, NC 27705, USA; david.pisetsky ... |
| 7/1/2019 |
EQS-Adhoc: AEVIS VICTORIA: Medical Properties Trust acquires a 4.9% shareholding in AEVIS VICTORIA SA |
Business Insider |
... Trust (MPT) has acquired a 4.9% shareholding in AEVIS VICTORIA SA (AEVIS), corresponding to 3'850'961 registered shares. MPT is now the second largest shareholder of AEVIS after the Group Hubert/Reybier/M.R.S.I. Medical Research Service s and Investments SA. MPT is a strategic investor listed on the New York Stock Exchange and exclusively specialised in hospital buildings for nearly 20 years. A month ago, MPT became the largest shareholder ... |
| 5/14/2019 |
Unexpected link between mitochondrial DNA and T cell help in systemic lupus erythematosus |
BMJ |
Unexpected link between mitochondrial DNA and T cell help in systemic lupus erythematosus David S Pisetsky Department of Medicine and Immunology , Duke University Medical Center; and Medical Research Service , VA Medical Center , Durham , North Carolina , USA Correspondence to Dr David S Pisetsky, VA Medical Center, Medical Research Service , Durham, NC 27705, USA; david.pisetsky(at)duke.edu disease activity Since the discovery of anti-DNA antibodies, DNA has been the subject of ... |